A synthetic method for peptide-PEG-lipid conjugates: Application of Octreotide-PEG-DSPE synthesis

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 16, 2008, Pages 4593-4596

  Su, Jian Chiou ^a   Tseng, Chin Lu ^b   Chang, Ting Gung ^b   Yu, Wen Jen ^c   Wu, Shih Kwang ^a,b,c  

^a KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^b DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Drug delivery; Octreotide; Peptide PEG lipid conjugates; Targeted liposomes

Indexed keywords

DISTEARYLPHOSPHATIDYLETHANOLAMINE; ETHANOLAMINE DERIVATIVE; LIPID; LIPOSOME; MACROGOL; MACROGOL 2000; OCTREOTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; LIPOSOMAL DELIVERY; SOLID PHASE SYNTHESIS;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY; DRUG DELIVERY SYSTEMS; KINETICS; LIGANDS; LIPIDS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CHEMICAL; MOLECULAR CONFORMATION; OCTREOTIDE; PEPTIDES; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 48849104242     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.07.027     Document Type: Article

References (20)

1. Sapra P., Tyagi P., and Allen T.M. Curr. Drug Deliv. 2 (2005) 369
2. Noble C.O., Kirpotin D.B., Hayes M.E., Mamot C., Hong K., Park J.W., Benz C.C., Marks J.D., and Drummond D.C. Expert Opin. Ther. Targets 8 (2004) 335
3. Sofou S., and Sgouros G. Expert Opin. Drug Deliv. 5 (2008) 189
4. Wu J., Lu Y., Lee A., Pan X., Yang X., Zhao X., and Lee R.J. J. Pharm. Pharm. Sci. 10 (2007) 350
5. Wu J., Liu Q., and Lee R.J. Int. J. Pharm. 316 (2006) 148
6. Zalipsky S., Mullah N., Harding J.A., Gittelman J., Guo L., and DeFrees S.A. Bioconjug. Chem. 8 (1997) 111
7. Reubi J.C. Endocr. Rev. 24 (2003) 389
8. Zalipsky S. Bioconjug. Chem. 4 (1993) 296
9. Lee T., Lin C., Kuo S., Chang D., and Wu H. Cancer Res. 67 (2007) 10958
10. Boeckler C., Frisch B., Muller S., and Schuber F. J. Immunol. Methods 191 (1996) 1
11. Patel Y.C., and Srikant C.B. Endocrinology 135 (1994) 2814
12. Florio T. Front. Biosci. 13 (2008) 822
13. Kwekkeboom D.J., and Krenning E.P. Eur. Radiol. 7 (1997) 1103
14. Delaunoit T., Rubin J., Neczyporenko F., Erlichman C., and Hobday T.J. Mayo. Clin. Proc. 80 (2005) 502
15. Arano Y., Akizawa H., Uezono T., Akaji K., Ono M., Funakoshi S., Koizumi M., Yokoyama A., Kiso Y., and Saji H. Bioconjug. Chem. 8 (1997) 442
16. Kaiser E., Colescott R.L., Bossinger C.D., and Cook P.I. Anal. Biochem. 34 (1970) 595
17. 2), 4.23 (1H, m, amino acid αH), 4.33 (2H, m, amino acid αH), 4.45 (1H, m, amino acid αH), 4.54 (1H, m, amino acid αH), 4.54 (2H, overlapping peaks, amino acid αH), 5.25 (1H, m, phospholiplid sn2-CH), 6.87 (1H, s, tryptophan H2), 6.94 (1H, dd, J = 7.70, 7.33 Hz, tryptophan H5), 7.03 (1H, dd, J = 7.75, 7.33 Hz, tryptophan H6), 7.10-7.23 (10H, overlapping peaks, phenyl H), 7.27 (1H, d, J = 7.75 Hz, tryptophan H7), 7.38 (1H, d, J = 7.70 Hz, tryptophan H4).
18. Bartlett G.R. J. Biol. Chem. 234 (1959) 446
19. Liapakis G., Fitzpatrick D., Hoeger C., Rivier J., Vandlen R., and Reisine T. J. Biol. Chem. 271 (1996) 20331
20. Patel Y.C., Greenwood M.T., Panettb R., Demchyshyn L., Niznik H., and Srikant C.B. Life Sci. 57 (1995) 1249